134 related articles for article (PubMed ID: 32145513)
1. Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity.
Guevara-Aguirre J; Teran E; Lescano D; Guevara A; Guevara C; Longo V; Gavilanes AWD
Growth Horm IGF Res; 2020 Apr; 51():58-64. PubMed ID: 32145513
[TBL] [Abstract][Full Text] [Related]
2. GH Receptor Deficiency in Ecuadorian Adults Is Associated With Obesity and Enhanced Insulin Sensitivity.
Guevara-Aguirre J; Rosenbloom AL; Balasubramanian P; Teran E; Guevara-Aguirre M; Guevara C; Procel P; Alfaras I; De Cabo R; Di Biase S; Narvaez L; Saavedra J; Longo VD
J Clin Endocrinol Metab; 2015 Jul; 100(7):2589-96. PubMed ID: 25985182
[TBL] [Abstract][Full Text] [Related]
3. Brain Structure and Function Associated with Younger Adults in Growth Hormone Receptor-Deficient Humans.
Nashiro K; Guevara-Aguirre J; Braskie MN; Hafzalla GW; Velasco R; Balasubramanian P; Wei M; Thompson PM; Mather M; Nelson MD; Guevara A; Teran E; Longo VD
J Neurosci; 2017 Feb; 37(7):1696-1707. PubMed ID: 28073935
[TBL] [Abstract][Full Text] [Related]
4. Despite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives.
Guevara-Aguirre J; Procel P; Guevara C; Guevara-Aguirre M; Rosado V; Teran E
Growth Horm IGF Res; 2016 Jun; 28():76-8. PubMed ID: 26259979
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency.
Bachrach LK; Marcus R; Ott SM; Rosenbloom AL; Vasconez O; Martinez V; Martinez AL; Rosenfeld RG; Guevara-Aguirre J
J Bone Miner Res; 1998 Mar; 13(3):415-21. PubMed ID: 9525342
[TBL] [Abstract][Full Text] [Related]
6. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
7. MECHANISMS IN ENDOCRINOLOGY: Transient juvenile hypoglycemia in growth hormone receptor deficiency - mechanistic insights from Laron syndrome and tailored animal models.
Hinrichs A; Renner S; Bidlingmaier M; Kopchick JJ; Wolf E
Eur J Endocrinol; 2021 Jul; 185(2):R35-R47. PubMed ID: 34048365
[TBL] [Abstract][Full Text] [Related]
8. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
9. Growth Hormone Receptor Antagonist Transgenic Mice Have Increased Subcutaneous Adipose Tissue Mass, Altered Glucose Homeostasis and No Change in White Adipose Tissue Cellular Senescence.
Comisford R; Lubbers ER; Householder LA; Suer O; Tchkonia T; Kirkland JL; List EO; Kopchick JJ; Berryman DE
Gerontology; 2016; 62(2):163-72. PubMed ID: 26372907
[TBL] [Abstract][Full Text] [Related]
10. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
[TBL] [Abstract][Full Text] [Related]
11. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
[TBL] [Abstract][Full Text] [Related]
12. Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency.
Guevara-Aguirre J; Rosenbloom AL
Diabetologia; 2015 Jan; 58(1):37-42. PubMed ID: 25316432
[TBL] [Abstract][Full Text] [Related]
13. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 cotreatment versus insulin-like growth factor-I alone in two brothers with growth hormone insensitivity syndrome: effects on insulin sensitivity, body composition and linear growth.
Ekström K; Carlsson-Skwirut C; Ritzén EM; Bang P
Horm Res Paediatr; 2011; 76(5):355-66. PubMed ID: 21968387
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
16. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
[TBL] [Abstract][Full Text] [Related]
17. GH and GHR signaling in human disease.
Guevara-Aguirre J; Guevara A; Palacios I; Pérez M; Prócel P; Terán E
Growth Horm IGF Res; 2018 Feb; 38():34-38. PubMed ID: 29395968
[TBL] [Abstract][Full Text] [Related]
18. Cancer in Ecuadorian subjects with Laron syndrome (ELS).
Guevara-Aguirre J; Peña G; Pazmiño G; Acosta W; Saavedra J; Lescano D; Guevara A; Gavilanes AWD
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36971780
[TBL] [Abstract][Full Text] [Related]
19. Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.
Guevara-Aguirre J; Bautista C; Torres C; Peña G; Guevara C; Palacios C; Guevara A; Gavilanes AWD
Rev Endocr Metab Disord; 2021 Mar; 22(1):59-70. PubMed ID: 33047268
[TBL] [Abstract][Full Text] [Related]
20. Normal or improved cardiovascular risk factors in IGF-I-deficient adults with growth hormone receptor deficiency.
Guevara-Aguirre J; Mishra A; Canepa M; Guevara C; Villacres Á; Guevara A; Peña G; Lescano D; Kopchick JJ; Balasubramanian P; Longo VD
Med; 2024 Apr; ():. PubMed ID: 38677286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
